It looks like England has approved KeyTruda for use in early mTNBC. Leronlimab should perform so much better than a checkpoint inhibitor. We need to get our treatment back into action. Every day, it makes me sick that Leronlimab is stopped in its tracks. To be able to treat these horrible afflictions, without poisoning the patient, is what I most dearly wish for. If not for the actions of a few, our drug would certainly improve the world.

https://www.fiercepharma.com/pharma/novavax-n...tinues-lag
The article is midway down the page.

GLTUA